Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice

Laboratory Investigation

Volumn 86, Issue 1, 2006, Pages 45-53

  Amann, Kerstin ^a   Faulhaber, Jörg ^b   Campean, Valentina ^a   Balajew, Vitali ^c   Dono, Rosanna ^d   Mall, Gerhard ^e   Ehmke, Heimo ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d AIX MARSEILLE UNIVERSITÉ   (France)

^e Department of Pathology ^*  (Germany)

Author keywords

ANG II; Capillaries; FGF2; Heart; Myocardial hypertrophy

Indexed keywords

ANGIOTENSIN II; FIBROBLAST GROWTH FACTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; HEART MUSCLE CAPILLARY; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULARIZATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CAPILLARIES; CORONARY CIRCULATION; FIBROBLAST GROWTH FACTOR 2; MICE;

EID: 32844464494     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700359     Document Type: Article

References (51)

1. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, et al. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-840.
2. Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ 1986;19:1-17.
3. Akimoto T, Hammerman MR. Fibroblast growth factor 2 promotes microvessel formation from mouse embryonic aorta. Am J Physiol Cell Physiol 2003;284:C371-C377.
4. Yokoyama M, Hirase T. Harmonic interplay of angiogenic growth factors in the development of coronary blood vessels. Circ Res 2001;88:1099-1101.
5. Dono R, Texido G, Dussel R, et al. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 1998;17:4213-4225.
6. Dono R, Faulhaber J, Galli A, et al. FGF2 signaling is required for the development of neuronal circuits regulating blood pressure. Circ Res 2002;90:E5-E10.
7. Zhou M, Sutliff RL, Paul RJ, et al. Fibroblast growth factor 2 control of vascular tone. Nat Med 1998;4:201-207.
8. Dono R. Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 2003;284:R867-R881.
9. Ortega S, Ittmann M, Tsang SH, et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998;95:5672-5677.
10. Montero A, Okada Y, Tomita M, et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 2000;105:1085-1093.
11. Schultz JE, Witt SA, Nieman ML, et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999;104:709-719.
12. Goto F, Goto K, Weindel K, et al. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993;69:508-517.
13. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 1995;19:431-444.
14. Battler A, Scheinowitz M, Bor A, et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 1993;22:2001-2006.
15. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996;94:1074-1082.
16. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995;91:145-153.
17. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997;3:158-164.
18. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-1403.
19. Davis MG, Zhou M, Ali S, et al. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J Mol Cell Cardiol 1997;29:1061-1072.
20. Schweigerer L, Neufeld G, Friedman J, et al. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987;325:257-259.
21. Kardami E, Fandrich RR. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J Cell Biol 1989;109:1865-1875.
22. Casscells W, Speir E, Sasse J, et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990;85:433-441.
23. Speir E, Tanner V, Gonzalez AM, et al. Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ Res 1992;71:251-259.
24. Clarke MS, Caldwell RW, Chiao H, et al. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res 1995;76:927-934.
25. Pasumarthi KB, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res 1996;78:126-136.
26. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
27. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999;98:147-157.
28. Cleaver O, Melton DA. Endothelial signaling during development. Nat Med 2003;9:661-668.
29. Gerber HP, Hillan KJ, Ryan AM, et al. VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-1159.
30. Lijnen P, Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999;31:949-970.
31. Tornig J, Amann K, Ritz E, et al. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 1996;7:667-675.
32. Mattfeldt T, Mall G, Gharehbaghi H, et al. Estimation of surface area and length with the orientator. J Microsc 1990;159:301-317.
33. Henquell L, Honig CR. Intercapillary distances and capillary reserve in right and left ventricles: significance for control of tissue po2. Microvasc Res 1976;12:35-41.
34. Hollander GA, Zuklys S, Morel C, et al. Monoallelic expression of the interleukin-2 locus. Science 1998;279:2118-2121.
35. Tomanek RJ, Haung L, Suvarna PR, et al. Coronary vascularization during development in the rat and its relationship to basic fibroblast growth factor. Cardiovasc Res 1996;31 Spec No:E116-E126.
36. Jin Y, Pasumarthi KB, Bock ME, et al. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J Mol Cell Cardiol 1994;26:1449-1459.
37. Mima T, Ueno H, Fischman DA, et al. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA 1995;92:467-471.
38. Shou M, Thirumurti V, Rajanayagam S, et al. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol 1997;29:1102-1106.
39. Sullivan CJ, Doetschman T, Hoying JB. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 2002;93:2009-2017.
40. Tomanek RJ, Sandra A, Zheng W, et al. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ Res 2001;88:1135-1141.
41. Mall G, Zimmer G, Baden S, et al. Capillary neoformation in the rat heart - stereological studies on papillary muscles in hypertrophy and physiologic growth. Basic Res Cardiol 1990;85:531-540.
42. Amann K, Wiest G, Zimmer G, et al. Reduced capillary density in the myocardium of uremic rats - a stereological study. Kidney Int 1992;42:1079-1085.
43. Amann K, Breitbach M, Ritz E, et al. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998;9:1018-1022.
44. Amann K, Ritz E. Microvascular disease - the Cinderella of uraemic heart disease. Nephrol Dial Transplant 2000;15:1493-1503.
45. Carmeliet P, Ng YS, Nuyens D, et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999;5:495-502.
46. Larkin JE, Frank BC, Gaspard RM, et al. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 2004;18:152-166.
47. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
48. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
49. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1:1085-1089.
50. Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res 1999;84:633-646.
51. Wiesner RJ, Ehmke H, Faulhaber J, et al. Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 1997;95:1253-1259.